HIW Highwoods Properties, Inc.
Highwoods Properties, Inc. is a publicly traded fully integrated office real estate investment trust that owns, develops, acquires, leases and manages properties primarily in the best business districts (BBDs) of Atlanta, Charlotte, Dallas, Nashville, Orlando, Raleigh, Richmond and Tampa. The firm's vision is to be a leader in the evolution of commercial real estate for the benefit of customers, their communities and those who invest with them. Highwood Properties' mission is to create environments and experiences that inspire their teammates and their customers to achieve more together. They are in the work-placemaking business and believe that by creating exceptional environments and experiences, they can deliver greater value to customers, their teammates and, in turn, their shareholders. Highwoods Properties, Inc., is headquarters in Raleigh. Highwoods Properties, Inc. was incorporated in 1978 in Maryland, USA.…
Industry Peers
REIT - OfficeKey Statistics
About Highwoods Properties (NYSE: HIW)
›
Highwoods Properties (NYSE: HIW) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the REIT - Office industry, part of the Real Estate sector, and reports about 315 employees.
The shares were at 29.81 USD on 19 November 2026, up 8.5% over 52 weeks. Its 52-week range is 20.45 USD to 35.44 USD: the price is 15.9% below the high and 45.8% above the low.
At a market capitalisation of 3.35B USD, it trades at 17.7 times trailing earnings and 52.3 times forward earnings. The median trailing P/E of its 14 largest REIT - Office peers is 20.3, a discount of 12% for HIW. It pays a dividend yielding 6.49% (it pays out 119% of its earnings), against a median of 5.53% among the dividend payers in that peer group.
Highwoods Properties reports return on equity of 6.7%, an operating margin of 26.1% and revenue up 8.2% year over year.
Its debt exceeds its cash by 3.23B USD, a debt-to-equity ratio of 1.49. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 9 analysts cover the stock, with an average rating of Hold; their mean price target of 31.44 USD is 5.5% above the current price. The next earnings report is expected on 9 February 2027.